Changes in Axial Length and Refraction After Gradual Versus Prompt Cessation of Atropine 0.01% Treatment for Myopia Management
The findings indicate that neither gradual nor prompt discontinuation of 0.01% atropine resulted in statistically significant differences in myopia progression. These results suggest no significant differences in myopia progression after treatment cessation between the two methods and provide no evidence of a rebound effect.
Authors
- Shani Morad
- David Landau (ORCID: https://orcid.org/0000-0003-1770-9086)
- N. London (ORCID: https://orcid.org/0000-0001-6935-3275)
- Shehzad A. Naroo (ORCID: https://orcid.org/0000-0002-6373-7187)
- Yair Morad (ORCID: https://orcid.org/0000-0003-0222-8386)
- Asaf Shemer (ORCID: https://orcid.org/0000-0002-4366-5438)
- Biana Dubinsky‐Pertzov (ORCID: https://orcid.org/0000-0002-4998-8772)
- Eran Pras
- Nir Erdinest (ORCID: https://orcid.org/0000-0003-3327-0173)
- Moshe Y. Vardi (ORCID: https://orcid.org/0000-0001-6554-8622)
Institutions
- Tel Aviv University (IL)
- St George's, University of London (GB)
- Aston University (GB)
- Hebrew University of Jerusalem (IL)
- American Optometric Association (US)
- Hadassah Medical Center (IL)
- Rabin Medical Center (IL)
- Jerusalem University College (IL)
- College of Optometrists (GB)
- Assaf Harofeh Medical Center (IL)
- University of Pharmacy Yangon (MM)
- SUNY College of Optometry (US)
Publication Details
- Journal
- Current Eye Research
- Published
- 2025-10-08
- DOI
- https://doi.org/10.1080/02713683.2025.2567593
- Citations
- 1
- Primary Topic
- Ophthalmology and Visual Impairment Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.35